This can be achieved through identifying phytochemicals that not only inhibit SGLT2 but also have other beneficial properties for diabetes, such as improved insulin signaling and glycemic regulation, reduction in the inflammation and oxidative stress associated with diabetic nephropathy [55], and even reduction in hepatic gluconeogenesis and fat absorption in obesity. The gene discussed is SLC5A2; the disease is diabetic kidney disease.